Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2022-08-17 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled as an 'RNS Number' notification from the London Stock Exchange's news service. The content is structured as a 'TR-1: Standard form for notification of major holdings,' detailing changes in voting rights held by BlackRock, Inc. This type of filing, which reports changes in significant share ownership crossing regulatory thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory disclosure about share ownership changes, making MRQ the most precise classification over the general RNS fallback.
2022-08-17 English
Change of Auditor
Audit Report / Information Classification · 99% confidence The document is an RNS announcement dated August 8, 2022, identified by the 'RNS Number : 1693V' header. The core subject is the 'Change of Auditor,' specifically announcing the appointment of Deloitte LLP and the resignation of KPMG LLP, referencing sections 519 and 520 of the Companies Act 2006. This type of corporate governance update, which involves changes to key professional advisors (like auditors), falls under general corporate governance or regulatory announcements. Since there is no specific category for 'Auditor Change,' and it is a formal regulatory disclosure distributed via RNS, it best fits the general 'Regulatory Filings' category (RNS) or potentially 'Governance Information' (CGR). However, given the structure as a brief, immediate release via the RNS system, RNS is the most appropriate catch-all for formal, non-financial-result-specific regulatory news. The document length is short (under 5,000 characters), and it is an announcement, not the full audit report itself. FY 2022
2022-08-08 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short notification released via RNS (RNS Number: 5240U) on August 1, 2022. The content explicitly states that the company is making a notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1 regarding 'Total Voting Rights'. It provides the total number of issued shares and the resulting total voting rights. This type of mandatory disclosure regarding the total number of shares/voting rights, often released when there is no change or as a routine update, fits best under the general regulatory announcement category, as it is not a specific financial report (10-K, IR), management change (MANG), or dividend notice (DIV). Given the context of a mandatory regulatory disclosure that doesn't fit a more specific category like DIRS or MRQ, RNS (Regulatory Filings) is the most appropriate fallback, although it is closely related to share capital changes. However, since it is a specific notification about voting rights denominator required by FCA rules, and not a general announcement of a report (RPA), RNS is the best fit among the provided options for miscellaneous regulatory updates.
2022-08-01 English
Half Year Trading Update
Earnings Release Classification · 100% confidence The document is titled "Half Year Trading Update" and provides key financial metrics (revenue, margin, free cash flow, debt) for the six months ended 30 June 2022. It discusses performance against the prior period (H1 21) and reiterates full-year guidance, explicitly mentioning that the full interim results are expected on 20 September 2022. This structure—a summary of performance for a period shorter than a year, released before the full formal report—is characteristic of an Interim/Quarterly Report (IR). It is more detailed than a simple Earnings Release (ER) but less comprehensive than a full Annual Report (10-K). The presence of the RNS header and the MAR disclosure confirms it is a regulatory filing, but the content specifically points to an IR. H1 2022
2022-07-20 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short notification released via RNS (RNS Number: 0050R) on 01 July 2022. The content explicitly states the 'Total Voting Rights' as of 30 June 2022, referencing the FCA's Disclosure and Transparency Rule 5.6.1. This type of filing, which reports the total number of shares and voting rights, is a mandatory regulatory disclosure. Since it does not fit the specific definitions for AGM materials, Director's Dealing, Capital Changes, or Dividend Notices, and it is a direct regulatory announcement, it best fits the general 'Regulatory Filings' category (RNS) or potentially a specific voting rights announcement if one existed. Given the provided definitions, 'Regulatory Filings' (RNS) is the most appropriate general category for mandatory, non-periodic regulatory updates that don't fit elsewhere. However, looking closely at the definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) covers official results from shareholder votes. While this is about the denominator for voting rights calculation rather than the *results* of a vote, it is highly related to voting mechanics. Since DVA is defined as 'Official results from shareholder votes at any general meeting (AGM or EGM)', and this is a routine update on the total number of shares/voting rights (often required under DTR 5.6.1), it is a specific regulatory disclosure. If DVA is strictly for *results*, then RNS is the fallback. Given the context of DTR 5.6.1, this is a standard regulatory disclosure. I will classify it as RNS as it is a general regulatory announcement provided via the RNS system, which serves as the fallback for miscellaneous regulatory filings.
2022-07-01 English
Block Listing Six Monthly Return
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is providing information via 'RNS, the news service of the London Stock Exchange'. The content details a 'Block Listing Six Monthly Return' covering the period from December 2021 to June 2022, relating to the allotment and balance of securities under various share option plans. This type of routine regulatory update, which is not a core financial report (like 10-K or IR) or a specific announcement like a dividend or management change, fits best under the general regulatory announcement category, RNS. Although it contains specific data, it is presented as a formal regulatory filing notification rather than a comprehensive report or a simple announcement of a report's publication (RPA).
2022-06-30 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.